Mobile App

Google Play Apple Store
Current Clinical Controversies in HCV Care - Updated 12/7/2017
Certified CME/CNE/CPE Activity - Mini Modules
The refinement of therapy for hepatitis C virus (HCV) infection continues with improved cure rates and availability of simplified, single-tablet, pan-genotypic HCV regimens. Although data from clinical trials provide general estimates of safety and efficacy in a controlled setting, there remains a need to evaluate how clinical trial data translates to the real-world setting.

These educational Mini Modules will outline current clinical controversies in HCV testing and treatment that may impact outcomes with HCV therapy, relying on key studies and real-world experiences.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Review one (or all) Mini Modules of interest. Claim AMA, ANCC, or ACPE credit/contact hour(s) per module after completion of each brief Post-Test/Evaluation.
David Nelson, MD
David Nelson, MD
Professor of Medicine
Vice President of Research
University of Florida



 


20
Supported by an independent educational grant from Gilead Sciences Medical Affairs
Expired Activity
Mini Module
6133
LiverDisease